Guidelines
for purchases under
Consolidated User Fee Fund
Issued by:
State Health Society, Haryana
27-12-2013
Page 1 of 53
PURCHASES UNDER CONSOLIDATED USER FEE FUND
1.0
BACKGROUND :
Reference is made to the Government Order Memo No 20/98/2000-5HB-III dated
12-08-2003 and Memo No 3/78/92-HB-III dated 16-01-2004 & 22-01-04 vide which
the Swasthya Kalyan Samitis were allowed to retain the user fee and utilise the
retained amount for up gradation and modernising the health care services. Various
guidelines have since been issued from time to time to guide the SKS to make rational
utilisation of these funds. Most of the restrictions imposed earlier were with the
intention of ensuring that sanctioned funds under State and NRHM funds are not left
un-utilised because of flexibility of utilisation of the user money funds. In order to
make improvement of the health facilities, the guidelines are revised.
2.0
SCOPE:-
These guidelines define the delegated powers of the authority to purchase various
items required for improvement in health facilities including medicines and
consumables at various health institutions. They also define the conditions under
which purchase is permitted and specified to the maximum limits by following the
prescribed purchase procedure. The powers described in this document would be
able to guide all health administrative authorities (SKSs, PMO/SMOs and MOs) to
make purchases and to incur other expenditures out of User fee in order to facilitate
the improvement in the health institutions.
3.0
MERGER OF SPP, IPP AND USER FUNDS FOR VARIOUS PURCHASES
3.1 Justification:
The merger of receipt under User charges, SPP and IPP is necessary
 To have an overall outlook of the finances available with an institution.
 To avoid difficulties being experienced in the maintenance of separate
accounts of these programmes.
 To avoid confusion with respect to purchase of similar items under different
heads and to avoid the purchases of medicines and consumables by different
departments of hospital in respect of SPP, IPP and User funds. These items
being of similar nature are not ordered as consolidated resulting in non
supply and short supply.
 To avoid overlapping in purchase of items, as currently, one department does
not know what the other department is purchasing.
Page 2
3.2 Revised Proposal
Now onwards all user charges received from SPP, IPP and user funds may be merged
in one account namely Consolidated User Charges fund and expenditure on all other
items as specified may be incurred out of this fund as per delegated powers.
However, State Budget and NRHM funds will remain separate to have proper
supervision and accountability of expenditure under those accounts. There will be
one store managed by one store in charge. For the purpose of accountability the
reporting on number of all surgeries should be done.
4.0
REVISION OF POWERS:-
The Haryana Government/State Health Society has been delegating powers to lower
level authorities under State budget, NRHM, SPP, IPP, User Fee from time to time, for
purchases including local purchase under various programmes. The powers of local
purchase delegated earlier need revision in view of increase in load of deliveries,
OPD, IPD and surgeries, in the various health institutions. The essential items are
either not supplied in time leading to stock outs or the rate contracts/approved
sources are not available. The various guidelines issued under the User Charges from
time to time, need to be revised. The powers for local purchase of medicines and
consumables required to run these programmes at District and Sub District levels
also need to be integrated in a single document.
4.1 Better Patient Care: It is envisaged from the very inception of the user
money scheme that it should be used for providing better facilities to patients and
attendants and improving patient care. Therefore this fund should be used for
building of new counters for patient registration, Drug Dispensing, lab sample
collection & report distribution; reducing patient wait time; increasing the seating
capacities in patient waiting areas; providing free medicines and free surgeries to all;
better surgical services; ensuring clean linen, maintenance etc as enumerated in
schedule A
4.2 Consolidated User Fee Funds:
Henceforth, all funds under IPP, SPP and User charges would be merged into a
Consolidated User Fee Fund and all expenditure would now be made from this fund.
i.
The guidelines below define the maximum power of various health
authorities to incur expenditure from this fund:
Page 3
SN
1
2
3
4
5
Level Of Institution
Authority
to
whom Amount
power delegated
District Hospitals of SKS (Hospital)
Up
to
200 bedded and
20,00,000/above
including
per month
Panchkula.
District Hospitals of
200 bedded and
above
including
Panchkula
District Hospitals of
100 but below 200
bedded including
GH
Bahadurgarh
and GH 10 Gurgaon
District Hospitals of
100 but below 200
bedded including
GH
Bahadurgarh
and GH 10 Gurgaon
Other Hospitals
Chairperson
(Hospital)
SKS(Hospital)
Chairperson
(Hospital)
SKS(Hospital)
SKS Up
1,00,000/per month
Remarks
Local Purchase
of
items
specified
in
schedule A as
per prescribed
purchase
procedure in
section 5
to -do-
Up
to -do10,00,000/per month
SKS Up
to -do1,00,000/per month
Up
to
7,00,000/per month
6
Other Hospitals
Chairperson
Up
to
SKS(Hospital)
75,000/- per
month
7
CHC/UHC/Polyclini SKS
(CHC) Up
to
c
UHC/Polyclinic
5,00,000/per month
8
CHC/UHC/Polyclini Chairperson SKS (CHC)/ Up
to
c
UHC/Polyclinic
50,000/- per
month
9
PHC/Dispensary
SKS
(PHC)
&
SKS Up
to
Dispensary
2,00,000/per month
10
PHC/Dispensary
Chairperson SKS (PHC) Up
to
& SKS Dispensary
10,000/- per
month
*CHC: Community Health Center, *UHC: Urban Health Center,
-do-do-do-do-do-do-
*PHC: Primary Health Center,
Page 4
ii.
iii.
iv.
v.
vi.
vii.
viii.
ix.
x.
The expenditure can be incurred for items specified in Annexure A to
these guidelines.
Each SKS should ensure that first funds available under State/NRHM
budget must be utilised before incurring expenditure under the
Consolidated User Fee Fund.
The Chairperson of the Executive Committee of the District Health and
Family Welfare Society may transfer the funds from one health facility to
another wherever required in the district.
The Chairperson of the Executive Committee of State Health Society may
be empowered for transfer of user fee funds as deemed necessary from the
district health institutions to the HQs for the purpose of meeting
deficiencies in services as and when required. The funds thus collected
should also be utilised for the strengthening of the Hospital Management
Division and Hospital Planning Division under the DGHS.
The Chairperson of the Executive Committee of State Health Society may
be empowered to transfer user fee funds from institution(s) located in one
district to another district with proper justification.
The PMO/SMO/MS would be competent to invite the tender for making
improvement in hospital services to the patients.
In case the funds are absolutely required for items falling under the heads
of NRHM Budget (like those defined in Schedule B) and are not specified
in Schedule A for running the health facilities efficiently, the SKS may
allow to use consolidated user fee funds subject to adjustment later on.
However the funds have to be recouped by the end of the Financial Year.
The Local Purchase of drugs and consumables should be done only after
computer generated. Non Availability Certificate (NAC) from the
warehouse for items to be provided from warehouse. The NAC once
obtained should be valid till the date of next indent. In case of part supply
the document showing part supply as compared to the indent should serve
as NAC. For drugs not to be supplied by warehouse and approved for Local
purchase (as in Schedule D and E) no NAC is required.
The earlier restriction of purchase of medicines only for 1 week is
henceforth removed. The SKS committee must plan the purchase of drugs
and consumables according to requirement. For those items which are to
be indented from warehouse in case of non supply (after obtaining NAC)
and in case of part supply, the purchase should be made for the period till
next indent. For items which are not to be supplied from warehouse the
purchases should be rationalised after examining the required quantity,
avoiding overstocking and also considering the economy of scale.
Page 5
xi.
xii.
xiii.
If the meeting of SKS is not feasible immediately, the PMO/SMO/MS would
also be authorized to make local purchase to the extent the of financial
power delegation made subject to final approval of SKS in the next
meeting.
The Facility in charges should ensure that Drugs and consumables should
be purchased keeping in view the actual requirement with proper
justification; Press tenders/ quotations where required should be invited;
regular meetings of SKS should be convened wherein requirements and
expenditure got approved; the doctors of the hospitals must be consulted
and transparency maintained.
There are certain items which are required for a longer period of time. In
order to get the benefit of scale it is envisaged that they should be
purchased at one go. However since the utilization of these items would be
spread over a longer period, it would not be financially appropriate to
book the entire expenditure in the month in which they are purchased.
Therefore the expenditure would be amortized by spreading the total
expenditure over a period of time for which it is proposed to be utilized.
Taking the example of X-ray films, if total monthly requirement of X-ray
films is of Rs 1,00,000 and the total yearly requirement would be Rs.
12,00,000. If the X-ray films are purchased for the entire year in month of
January, then instead of booking the whole expenditure on X-ray films i.e.
Rs 12,00,000 in the month of January, rather it should be
amortized/spread over 12 months at the rate of Rs 1,00,000 per month.
Even while the full payment to the vender would be made in the January
itself. As a result of this, the power of SKS committee would be available
for purchase of other items for the month of January i.e. Rs 19,00,000 will
be available out of the total power of Rs 20,00,000 if amortisation is done.
If amortisation is not done then the entire amount of Rs 12,00,000 would
be booked in January and balance of Rs 8,00,000 only will be available to
make purchases of other items during January. The corresponding power
of every month for remaining months of the year would be reduced to Rs
19,00,000. This system will in respect of other purchases for a longer
period of time.
5.0 REPORTING OF EXPENDITURE:
I.
Each District Accounts Manager should consolidate the monthly receipt
and expenditure district-wise and submit to MD NRHM and DGHS by 15th
of next month.
Page 6
II.
The detail of expenditures under all heads including detail of each item
(like all drugs and consumables) should be entered on Drug portal as and
when these are purchased which will be studied thoroughly to find major
expenditures occurring at all districts. It will help to reach at the decision
that which additional budget head needs to be sanctioned at state level and
which additional drug and consumable needs to be supplied from
warehouse.
6.0 PURCHASE PROCEDURE:
Items to be purchased should be further categorized into two types:6.1
6.2
For items other than Drug and consumable:- They should first be purchased
from approved sources. If not available on approved sources then purchase
procedure as specified in table should be followed.
For Drugs and consumables the following procedure should be followed:-
6.2.1 Drugs and consumables exclusively for local purchase:
Purchase may be made for appropriate period (3 months to 1 year) depending
on requirement, as per the procedure laid out below:
The purchases are of two kinds viz. Recurring and non-recurring.
a) Recurring Items:These are items which are required repeatedly
during the year.
In case of recurring items, tender would need to be invited where the
estimated annual demand for each item is more than one Lac.
In case the estimated annual demand is less than Rs. 1 lac, then purchases can
be made by inviting quotations. The tender/quotations thus finalized should
be valid for a period of 1 year from the date of finalization, so that repeated
orders can be placed on the vendor, during the period of validity.
b) Non-Recurring Items:- These are items which are required on a
particular occasion.
In case of non-recurring items purchase is to be made by way of press tenders,
if on a particular occasion value of an item is more than Rs1 lac, otherwise (for
item below 1 lac) purchases will be made through quotations.
For, the recurring items, the purchasing authority at district or hospital level
should estimate the demand of each item at the beginning of each financial
year and if the annual value of item exceeds Rs 1 lac then tender should be
Page 7
invited and supplier and rate fixed. In case the annual demand is estimated to
be less than 1 lac then quotations should be called as per procedure.
6.2.2 Drugs and consumables for which rate contract is still pending:
To make local purchases for the items whose RC is still pending, local
purchase can be made at the district and hospital level as per local purchase
guidelines as mentioned supra, till such time as rate contracts are finalized
and information is available on Web Portal that the supply of such items will
be made from the warehouses on a particular date.
6.2.3 Non supply or part supply from warehouse:
I.
Drugs and consumables which are on rate contract and orders have
been placed but supply is awaited at the warehouse : or
II.
Drugs and consumables have not been supplied as per indent received
from each Health Facility due to limited stock in warehouse : or
III.
Drugs and consumables which have not been issued to the Health
Facilities due to non-availability of the same in the warehouses :
In the all the conditions referred in 3 (I), 3 (II) and 3 (III), period of local purchase in
such cases should be from date of non supply of such items (against indent placed
with the warehouse) till the due date of next indent. In case such drugs and
consumables are not available in Warehouses even on the date of next indent further
repeat order can be made after recording proper justification of requirement of
items.
The procedure for local purchase in such cases should be only through quotations
irrespective of the amount involved (i.e even if the amount exceeds Rs. 1 lac/item) so
that uninterrupted supply chain can be maintained by making local purchases.
Page 8
6.3 Mode of purchase:
SNO.
1
2
3
MODE
Without quotation
With Quotation
Tender
EXISTING
REVISED POWERS
POWERS
Rs 1,000/- per Maximum upto Rs 2500/- per
occasion
occasion
 In case of ortho implants
Maximum upto Rs 10,000/per occasion
Rs 50,000/- per Maximum upto Rs 1,00,000/- per
occasion
occasion
Above 50,000/- Above Rs 1,00,000/- per occasion by
per occasion by
 Civil
Surgeon
for
Civil Surgeon.
PHCs,CHCs,UHC,Polyclinic,UD
and Sub Centers
 PMO/MS/SMO for Hospitals
* Any expenditure required to be made which is beyond Rs 20,00,000/- per
month should be incurred after prior approval of Chairperson of State Health
Society
7.0 REVISION OF ESSENTIAL DRUG LIST (EDL) OF HARYANA AND
CATEGORISATION BASED ON ITS LEVEL OF PURCHASE:
The Committee under the DGHS Haryana, in its meeting on 19-12-2013 revised the
EDL and deleted 90 number of medicines and 113 components in existing EDL.
Now the revised EDL contains 283 drugs and 427 components (Components means
different dosage forms and strengths of the same salt), categorized them into 3 parts:



EDL-RC (Schedule C)
EDL-Non-RC. (Schedule D)
Non-EDL Drugs. List of drugs from Standard Treatment Guidelines (STG).
(Schedule E)
The categorization is also done on the basis of level of purchase.
a) State Level Purchase List: These drugs have a Rate Contract (RC) and would be
purchased at state level and supplied through the warehouses. List attached as
Schedule C.
Page 9
b) District/Institution Level Purchase List:
i)
EDL-RC Drugs: Non-availability of medicines in warehouse as per EDLRC drugs may be purchased after getting Non Availability Certificate
(NAC).
ii)
EDL-Non-RC Drugs: List of EDL medicines approved for local Purchase
attached as Schedule D. These drugs are contained in the EDL and do
not have an RC therefore should be purchased locally. These are
essential drugs which are required in small quantities in emergencies
or/and in uncommon conditions. These are essential drugs which
should be purchased and made available in adequate quantities at all
times.
iii)
Non-EDL drugs:
a) These are drugs drawn from Standard Treatment Guidelines (STG)
which may be purchased locally as they are required in small
quantities and in uncommon conditions Schedule E.
b) In addition to the above lists, the local purchase may also be done
by SKS with proper justification recorded in its minutes for any
medicines or consumables required for treatment of any particular
patient.
8.0
SUPERSESSION OF ALL EARLIER GUIDELINES:
These guidelines would supersede all instructions/ guidelines/clarifications
issued from time to time, under user fee, SPP and IPP programmes.
Page 10
9.0 SCHEDULES AND ANNEXURES
SCHEDULE A
SNO
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Activity/ Item
Lab Articles
POP Bandages for Emergency
Ortho Implants
Dental Articles
X Ray/ USG Films
Remarks
Including reagents and kits
The implants must be of Indian make
Like printing of OPD cards, Indoor
Printing & Stationary items
files etc.
Items required in Mortuary
Medical Gases
Contractual Remuneration to the Only with respect to staff sanctioned
employees
by HQ (MD NRHM/DGHS)
This can include electrical fittings
and maintaining public health
facilities excluding major civil works.
This expenditure may be incurred
only after expiry of AMG and with
For Infrastructure improvements
prior approval of MD, NRHM/DGHS
Items required for Sanitation
Include computer, machinery like
lifts,
generators,
biomedical
equipments, Dental chair/ units etc.
AMC/CMC should only be done if
Maintenance/ Repair/AMC/CMC of funds are not available from regular
equipments
sources of state
Linen, mattress, beds and Blankets
Purchases under SPP
Purchases under IPP
Repair and maintenance and
upkeep of health institutions
Drugs and consumables as per
defined conditions in Section 6.0
Water/
electricity/
Landline In case of non availability of funds
telephone Bills
under state budget.
Contractual
Remuneration
to Only with prior approval of HQ (MD
Specialist where found deficient
NRHM/ DGHS)
Improvement of Boarding lodging
arrangement for patients and
attendants
Page 11
21
22
23
24
25
26
27
Contracting
out/outsourcing
services like cleaning, laundry,
cooking, diagnostic services
POL for Gen sets
Drinking water facilities
Surgical
and
Examination
instruments
Minor equipments
These services only with prior
approval of MD/DGHS if no funds are
available under state/NRHM.
like Dental instruments
Costing less than Rs 10,000 per
equipment
Purchases for Biomedical Waste
Managment
Other items
With prior
NRHM/DGHS
approval
of
MD
*Imp. User Fee Fund should not be spent on items otherwise to be procured from
NRHM or State budget. NRHM budget to be spent at institute level should be
deposited and maintained in separate account and expenditure should be
incurred by following these guidelines unless otherwise directed in any case.
Page 12
Schedule B
1. On the basis of examination of expenditure of District Hospital, the user fee is
being spent on items for which the budget was specifically provided by NRHM for
e.g. on free delivery , and free caesarian, free diagnostics to Antenatal cases. In
future however the money may continued to be spent for these activities from
user fee fund if required but should be replenished from the respective
programme fund within that financial year.
a. Jannni Shishu Suraksha Karyakaram (JSSK) Normal Delivery and Caesarean
Section.
b. Eye Surgeries
c. Cleft Lip; Cleft Palate; Tongue Tie operations.
d. Any Other Scheme of the State & GOI
Page 13
Schedule - C
Revised Haryana Essential Drug List with Rate Contract (To be purchased at state level)
*Total Drugs = 242
*Total Components = 375
* All drugs to be dispensed in OPD will be made available in IPD as and when required.
* All drugs in OPD, IPD should be made available in OT as and when required.
* The column IPD combines the drugs to be made available at different work stations of the
hospital like wards, Injection Room, Labour Room, Emergency department, ICU, SNCU, Minor OT or
any other.
Sr.
No.
Com
p.Sr. Medicines
No
Dosage
Forms
Strength
Category
GH
1
1
2
2
3
3
4
4
5
5
6
6
1. ANAESTHETICS
1.1 General anesthetics and oxygen
3% to 5%
in
oxygen/Nit
Halothane
Inhalation
rous Oxide.
Maint 0.51%,(250ml
)
Injection, (as
50 mg
Ketamine
hydrochloride /ml,10 ml
)
vial
Injection
Thiopenton
(sodium)
0.5 g
e
Powder
Midazolam Injection
1 mg/ml
1% vial
Propofol
Injection
(10mg/ml
,10 ml vial)
*Isoflurane
*Purchase
in small
quantity & Inhalation
100 ml
prescriptio
n has to be
monitored
CHC
Usage
PHC
/UD
Sub
centre
OPD
IPD OT
GH
GH
OT
CHC
OT
GH
GH
OT
CHC
OT
GH
OT
GH
OT
Page 14
7
7
8
8
9
10
11
9
10
11
12
13
12
14
15
13
16
14
17
15
18
Fentanyl
Injection
Sevofluran
Inhalation
e
1.2 Local anaesthetics
Bupivacain
e For
epidural &
local
anesthesia
Injection
(hydrochlorid
e)
Bupivacain
e heavy 5
mg with
Dextrose
Monohydra Injection
te 80
mg/ml for
Spinal
Anaesthesi
a
Jelly sterile
Lignocaine
Jelly sterile
Hydrochlor
ide
Injection
25 mcg/ml
(2ml)
GH
OT
250 ml
GH
OT
0.5% 5 ml
ampoule
GH
CHC
OT
5 mg + 80
mg/ml,4 ml GH
ampoule
CHC
OT
2%, 30 gm GH CHC PHC
IPD
5%, 20 gm GH CHC PHC
IPD
2%, 30 ml
Sub
GH CHC PHC
IPD
vial
centre
Lignocaine
2% +
Hydrochlor
Adrenaline
Injection
GH CHC PHC
IPD
ide +
1:80,000,
Adrenaline
30 ml vial
1.3 Preoperative medication and sedation for short-term procedures
0.5 mg/ml,
Injection
1 ml
GH CHC PHC
IPD OT
(sulphate)
ampoule
Atropine.
0.5 mg/ml,
Injection
20 ml
GH
IPD OT
(sulphate)
ampoule
0.2 mg/ml
Glycopyrol
Injection
1 ml
GH
IPD
ate
ampoule
5 mg/ml, 2
Diazepam
Injection
ml
GH CHC PHC
IPD
ampoule
2. ANALGESICS, ANTIPYRETICS, NON-STEROIDAL ANTI-INFLAMMATORY MEDICINES
Page 15
19
16
20
21
17
22
18
23
24
19
25
26
27
20
28
29
21
30
31
22
32
33
23
34
(NSAIMs), MEDICINES USED TO TREAT GOUT AND DISEASE MODIFYING AGENTS IN
RHEUMATOID DISORDERS (DMARDs)
2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)
Tablet
Sub
50 mg
GH CHC PHC
OPD
(sodium)
centre
25 mg/ml,
Diclofenac
Injection
3 ml
GH CHC PHC
IPD
Ampoule
Gel
1%
GH CHC PHC
OPD
Diclofenac
Sodium 50
mg +
50 mg +
Tablet
GH CHC PHC
OPD
Paracetam
325 mg
ol 325 mg
Tab
Tablet
200 mg
GH CHC PHC
OPD
Ibuprofen
Tablet
400 mg
GH CHC PHC
OPD
Thiocolchic
Tablet
4mg
GH CHC
OPD
oside
Sub
Tablet
500 mg
GH CHC PHC
OPD
centre
125
Sub
Suspension
mg/5ml,60 GH CHC PHC
OPD
centre
Paracetam
ml
ol
150
Injection
mg/ml,2 ml GH CHC PHC
IPD
ampoule
Drops
150 mg/ml GH CHC PHC
OPD
Aceclofena
Tablet
100 mg
GH CHC PHC
OPD
c 100mg
2.2 Opioid analgesics
Morphine
Tablet
10 mg
GH
IPD
Sulphate/H
ydrochlori
de
*Purchase
10 mg/ml,
in small
Injection
1ml
GH
IPD
quantity &
ampoule
prescriptio
n has to be
monitored
Tablet
50 mg
GH CHC
OPD
Tramadol
Hydrochlor
50 mg/ml
Injection
GH CHC
IPD
ide
2 ml
Page 16
ampoule
24
35
25
36
26
37
27
38
28
39
40
29
41
42
30
43
31
44
32
45
46
33
47
*Pentazoci
ne lactate
*Purchase
25 mg/ml,
in small
Injection
1 ml
GH CHC PHC
quantity &
Ampoule
prescriptio
n has to be
monitored
*Pethidine
Hydrochlor
ide
*Purchase
50 mg/ml,1
in small
Injection
ml
GH
quantity &
ampoule
prescriptio
n has to be
monitored
2.4Disease modifying agents used in rheumatoid disorders (DMARDs)
Hydroxy
Tablet
Chloroquin
200 mg
GH CHC
OPD
(Sulfate)
e
Sulfasalazi Tablet
500 mg
GH
ne
Methotraxa
Tablet
2.5 mg
GH
te
3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS
Tablet
10 mg
GH CHC PHC
5 mg/ml,60
Cetrizine
Suspension
GH CHC PHC
ml
Drops
10mg/ml
GH
Tablet
Chlorpheni
(hydrogen
4 mg
GH CHC PHC
ramine
maleate)
Phenirami
22.75
Injection
GH CHC PHC
ne maleate
mg/ml,2 ml
10 mg
GH CHC PHC
Hydroxyzin Tablet
e
Tablet
25 mg
GH CHC PHC
4 mg/ml,2
Dexametha Injection
ml
GH CHC PHC
sone
(disodium)
ampoule
IPD
IPD
OPD
OPD
OPD
Sub
OPD
centre
OPD
Sub
OPD
centre
Sub
centre
IPD
OPD
OPD
Sub
centre
IPD
Page 17
34
35
Hydrocorti
sone
49
50
10 mg
GH CHC PHC
OPD
20 mg
GH CHC PHC
OPD
Prednisolo
5mg/5ml,
ne
Suspension
GH
OPD
60 ml
There is no evidence for complete clinical similarity between prednisolone and
dexamethasone at high doses
4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING
4.2 Specific
Antisnake
venom(pol
Injection
10 ml vial
GH CHC PHC
yvalent
solution)
Antisnake
venom
(polyvalent Injection
10 ml vial
GH CHC PHC
solution)(D
ry Powder)
5. ANTICONVULSANTS/ANTIEPILEPTICS
Tablet
100 mg,
GH CHC PHC
OPD
Carbamaze
Tablet
200 mg
GH CHC PHC
OPD
pine
Suspension
20 mg/ml
GH CHC PHC
OPD
2 mg/ml 2
Injection
ml
GH CHC
ampoule
Lorazepam
Tablet
1 mg
GH CHC
OPD
Tablet
2 mg
GH CHC
OPD
36
52
37
53
38
54
55
56
57
40
58
59
60
Magnesium
sulphate
For use in
eclampsia
and severe
preInjection
eclampsia
and not for
other
convulsant
disorders
100 mg vial GH
500mg/ml,
1ml
ampoule
GH
CHC
CHC
PHC
Sub
centre
48
51
39
Powder for
injection
(sodium
succinate)
Tablet
Tablet
PHC
Sub
centre
IPD
IPD
IPD
IPD
IPD
Page 18
61
62
41
42
63
Tablet
Tablet
Phenobarbi
Suspension
tone
GH
GH
CHC
CHC
PHC
PHC
OPD
OPD
GH
CHC
PHC
OPD
GH
CHC
PHC
64
Injection
65
Tablet
(sodium)
100 mg
GH
CHC
PHC
OPD
Suspension
100 mg/ 5
ml
GH
CHC
PHC
OPD
50 mg/ml
GH
CHC
PHC
200 mg
GH
CHC
500 mg
GH
OPD
250 mg
GH
OPD
500 mg
GH
OPD
66
Phenytoin
67
68
43
69
70
44
30 mg
60 mg
20 mg/ 5
ml
200 mg/
ml
71
Sodium
valproate/
Valproic
acid
Divaloprex
Sodium
equivalent
to Valproic
Acid
Injection
(sodium)
Enteric coated
tablet
(sodium)
Enteric coated
tablet
(sodium)
Tablet
Tablet
IPD
IPD
OPD
6. ANTI-INFECTIVE MEDICINES
6.1.1 Intestinal anthelminthics
72
45
46
Chewable
tablet
400 mg
GH
CHC
PHC
Suspension
200 mg/5
ml
GH
CHC
PHC
6 mg
GH
73
Albendazol
e
74
6.1.2 Antifilarials
Ivermectin Tablet
Sub
OPD
centre
Sub
OPD
centre
OPD
6.2 Antibacterial
6.2.1 Beta Lactam medicines
75
47
76
Amoxicillin
77
Capsule
(anhydrous)
Capsule
(anhydrous)
Dispersible
Tablet
250 mg,
GH
CHC
PHC
OPD
500 mg
GH
CHC
PHC
OPD
125 mg
GH
CHC
PHC
OPD
Page 19
48
78
Tablet
79
Injection
80
81
Amoxicillin
+
clavulanic
acid
82
49
83
Ampicillin
84
50
85
Benzathine
penicillin
86
51
87
88
Cefixime
89
90
91
52
Injection
Injection
Dispersible
Tablet
Injection
powder
(sodium)
Injection
powder
(penicillin)
Injection
powder
Injection
powder
Tablet
Tablet
Dispersible
Tablet
500 mg +
125 mg
1gm + 200
mg
250 mg +
50 mg
500 +100
mg
200 mg
+28.5 mg
GH
CHC
OPD
GH
CHC
IPD
GH
CHC
IPD
GH
IPD
GH
CHC
500 mg
GH
CHC
6 lacs IU
vial
GH
IPD
GH
IPD
GH
IPD
12 lacs IU
vial
24 lacs IU
vial
100 mg
200 mg
OPD
PHC
IPD
GH
GH
CHC
CHC
PHC
PHC
OPD
OPD
50 mg
GH
CHC
PHC
OPD
Tablet
250 mg
GH
CHC
PHC
Tablet
500 mg
GH
CHC
PHC
GH
CHC
PHC
Cefadroxil
92
Syrup
93
Drops
125mg/ 5
ml,30ml
100 mg/
ml
GH
Sub
OPD
centre
Sub
OPD
centre
Sub
OPD
centre
OPD
6.2.1 Beta Lactam Medicines(Complementary)
94
53
95
96
97
54
98
Injection
250mg
GH
CHC
PHC
IPD
Injection
Injection
Injection
Ceftriaxone
powder
Powder
(sodium)
Injection
powder
1 gm
500 mg
GH
GH
CHC
PHC
IPD
IPD
250 mg
GH
CHC
PHC
IPD
1 g vial
GH
CHC
PHC
IPD
Cefotaxime
Page 20
6.2.2 Other antibacterial
99
55
100
Injection
Amikacin
101
56
102
103
104
105
57
106
58
107
108
59
109
110
Injection
Tablet
Tablet
Azithromyc Tablet
in
Suspension
Levofloxaci Tablet
n
Ofloxacin*
To be used
rationally
so as to
retain its
Tablet
senstivity
as
antitubercu
lar agent.
Tablet
Ciprofloxac
(hydrochlorid
in
e)
Final
Tablet
selection
(hydrochlorid
depends on
e)
indication
for use
Injection IV
60
111
Ciprofloxac
in
+Tinidazol
e
61
112
Doxycyclin
e
113
62
63
114
115
Injection
Erythromy
cin Base
Tablet
Capsule
(hydrochlorid
e)
Tablet
Oral
suspension
powder
Injection
100 mg,/2
ml
500 mg/2
ml
250 mg/2
ml
250 mg
500 mg
1 gm
200 mg/5
ml,15ml
GH
CHC
PHC
IPD
GH
CHC
PHC
IPD
GH
CHC
PHC
IPD
GH
GH
GH
CHC
CHC
PHC
PHC
OPD
OPD
OPD
GH
CHC
PHC
OPD
500 mg
GH
OPD
200 mg
GH
CHC
PHC
OPD
250 mg
GH
CHC
PHC
OPD
500 mg
GH
CHC
PHC
OPD
200 mg/
100 ml
GH
CHC
PHC
500 mg +
600 mg
GH
CHC
PHC
OPD
100 mg
GH
CHC
PHC
OPD
500 mg
GH
OPD
125 mg/5
ml,30ml
GH
OPD
40 mg/ ml,
GH
CHC
PHC
IPD
IPD
Page 21
Gentamyci
n
116
64
117
118
Metronidaz
ole
119
120
65
121
(sulphate)
2 ml vial
Tablet
200 mg
GH
CHC
PHC
Tablet
400 mg
GH
CHC
PHC
GH
CHC
PHC
GH
CHC
PHC
OPD
GH
CHC
PHC
Sub
OPD
centre
800 mg +
160 mg
GH
CHC
PHC
OPD
200 mg
GH
CHC
PHC
2%,30 gm
1%
w/v,15ml
GH
CHC
PHC
Sub
OPD
centre
OPD
GH
CHC
PHC
OPD
150 mg
GH
CHC
PHC
OPD
200mg
GH
OPD
50 mg
GH
OPD
Injection
Suspension
Sulfametho
xazole +
trimethopr
im
(Cotrimoxa
zole)
Tablet
Tablet
500 mg/
100ml
200 mg/50
ml
100 mg
+20 mg
Sub
OPD
centre
Sub
OPD
centre
IPD
6.3 Antifungal medicines
122
66
123
124
Pessaries
Clotrimazol
Cream
e
Solution
125
67
126
Fluconazol
e
127
Capsule/Tabl
et
Capsule/Tabl
et
Dispersible
Tablet
6.4 Antiviral medicines(Antiherpes medicines)
68
128
129
CHC
CHC
PHC
PHC
OPD
OPD
Tinidazole Tablet
500 mg
GH CHC
7. ANTIMIGRAINE MEDICINES FOR ACUTE ATTACK
Flunarazin
Tablet
10 mg
GH
e
8. ANTIPARKINSONISM MEDICINES
Tablet
Trihexyphe
(hydrochlorid 2 mg
GH
nidyl
e)
9. MEDICINES AFFECTING THE BLOOD
PHC
OPD
Acyclovir
Tablet
Tablet
200 mg
400 mg
GH
GH
6.5 Antiprotozoal medicines
69
130
70
131
71
132
OPD
OPD
Page 22
9.1 Antianaemia medicines
133
134
72
135
136
Ferrous
salt
Ferrous
salt
(sulphate)
Ferrous
salt (Iron
sucrose)
Ferrous
salt (Iron
sorbitol
citric acid
complex)
Tablet
Oral solution
OPD
GH
OPD
20mg/ml
GH
IPD
Injection
100 mg/
ml
GH
IPD
Tablet
138
Tablet Large
139
Tablet
Medium
73
GH
Injection
137
Ferrous
sulphate +
Folic acid
Equivalent
to 100 mg
elemental
iron
Equivalent
to 25 mg
iron /ml
140
Tablet Small
141
Syrup
142
Drops
Equivalent
to 60 mg
iron + 400
mcg folic
acid
Equivalent
to 100 mg
iron + 500
mcg folic
acid
Equivalent
to 45 mg
iron + 400
mcg folic
acid
Equivalent
to 20 mg
iron + 100
mcg folic
acid
Equivalent
to 100 mg
elemental
iron + 500
mcg folic
acid per 5
ml
GH
CHC
PHC
Sub
OPD
centre
GH
CHC
PHC
Sub
OPD
centre
GH
CHC
PHC
Sub
OPD
centre
GH
CHC
PHC
Sub
OPD
centre
GH
CHC
PHC
Sub
OPD
centre
GH
OPD
Page 23
74
75
143
144
145
146
76
147
148
77
149
78
150
79
151
80
152
153
154
155
81
156
82
157
158
83
159
Folic acid
Tablet
5mg
GH
CHC
PHC
9.2 Medicines affecting coagulation
Tablet
500 mg
GH CHC PHC
Ethamsylat Tablet
250 mg
GH CHC PHC
e
250 mg/2
Injection
GH CHC PHC
ml
9.2 Medicines affecting Coagulation(Complementary)
LMW
Injection
GH
Heparin
(LMW)
10 mg/ml,
1 ml
GH CHC PHC
ampoule,
Menadion
Sodium
Injection
1 mg/0.5
Bisulphite
ml water
GH CHC PHC
based
single dose
Purified
Freeze –
Dried
Human
Injection
250 IU
GH
Coagulatio
n Factor
VIII, Virus
inactivated
10. BLOOD PRODUCTS AND PLASMA SUBSTITUTES
Plasma
Volume
Injection
500ml
GH CHC PHC
Expander
11. CARDIOVASCULAR MEDICINES
11.1 Antianginal medicines
Atenolol
Tablet
50 mg
GH CHC PHC
Tablet
30 mg
GH
Diltiazem
Tablet
60 mg
GH
Injection
5 mg/ml
GH
500
Tablet
microgram GH CHC PHC
(sublingual)
s
Glycerine
Glycerine
0.5 mg
GH
trinitrate
trinitrate SR
Injection
(Nitro
5 mg/ ml
GH
Glycerine)
Isosorbide Tablet
5 mg
GH CHC PHC
Sub
OPD
centre
OPD
OPD
IPD
IPD
Sub
centre
IPD
IPD
IPD
Sub
centre
IPD
OPD
OPD
OPD
IPD
IPD
IPD
IPD
IPD
Page 24
OT
160
84
161
86
162
163
164
87
165
88
166
89
167
168
90
169
91
170
92
171
93
172
94
96
173
174
175
176
97
177
85
95
99
178
179
180
100
181
98
182
101
183
mononitrat
e
Isosorbide
dinitrate
Tablet
20 mg (SR)
GH
CHC
PHC
IPD
Tablet
5 mg
GH CHC PHC
IPD
(sublingual)
Tablet
25 mg
GH CHC PHC
OPD
Metoprolol
Tablet
50 mg
GH CHC PHC
OPD
Carvediolol Tablet
3.125 mg
GH
OPD
11.2 Antiarrhythmic medicines
Adenosine
(Phosphate Injection
3 mg/ ml
GH
IPD
)
Digoxin
Tablet
0.25 mg
GH CHC
OPD
11.3 Antihypertensive medicines
Tablet
5 mg
GH CHC PHC
OPD
Amlodipine Tablet
10 mg
GH CHC PHC
OPD
Enalapril
Tablet
5 mg
GH CHC PHC
OPD
Maleate
Hydrochlor
Tablet
25 mg
GH CHC PHC
OPD
othiazide
Methyldop
Tablet
250 mg
GH CHC PHC
OPD
a
Losartan
Tablet
50 mg
GH CHC PHC
OPD
HCL
Nifedipine Tablet (SR)
20 mg
GH
OPD
Tablet
2.5 mg
GH
OPD
Ramipril
Tablet
5 mg
GH
OPD
Labetalol
Tablet
100 mg
GH CHC
OPD
Telmisarta
Tablet
40mg
GH
OPD
n HCL
Methyldopa & Labetalol is listed for use in the management of pregnancy-induced
hypertension only. Its use in the treatment of essential hypertension is not recommended in
view of the availability of more evidence of efficacy and safety of other medicines.
11.5 Antithrombotic medicines
75 mg
GH CHC PHC
OPD
Acetylsalic Tablet
ylic acid
Tablet
150 mg
GH CHC PHC
OPD
Clopidogrel Tablet
75 mg
GH CHC
OPD
11.6 Thrombolytic
Streptokin Injection
1500000
GH
IPD
ase
powder
IU
Tablet
10 mg
GH CHC PHC
OPD
Atorvastati
n
Tablet
20 mg
GH CHC PHC
OPD
Page 25
102
184
185
103
186
104
187
105
188
106
189
107
190
108
191
109
192
110
193
111
194
112
195
113
196
114
197
115
198
116
199
11.7 Anti Fibrinolytic & Presser Agent
500 mg/5
Injection
ml
Tranexane
mic Acid
Tablet
500 mg
GH
CHC
GH
CHC
Mephenter Injection
30 mg/ml
GH
mine
12. DERMATOLOGICAL MEDICINES (topical)
12.1 Antifungal medicines
Cream
2%,15gm
GH CHC PHC
Miconazole (nitrate)
Clindamyci
1%
Cream
GH
n
w/w,10gm
12.1 Skin(Complementary)
Clobetasol
+
0.05% +
Ointment
GH CHC PHC
Gentamyci
0.1 %, 5gm
n
Permethrin
(Only for
Cream
5%, 30 gm GH CHC PHC
scabies)
12.2 Anti-infective medicines
Acyclovir
Cream
5%
GH
Silver
Sub
sulfadiazin Cream
1%,250mg GH CHC PHC
centre
e
12.3 Anti-inflammatory and antipruritic medicines
Cream
Betametha
(Dipropionate 0.1%
GH CHC PHC
sone
)
Calamine
Lotion
8%
GH CHC
lotion
Fluticasone Ointment
0.005%
GH
12.4 Medicines affecting skin differentiation and proliferation
Momaetaso
0.1%, 15
Lotion
ne Furoate
ml
GH
Fluocinolo
ne
Ointment
0.1%
GH
Acetonide
Benzoyl
2.5%, 10
Gel
Per Oxide
gm
GH
12.5 Scabicides and pediculicides
Gamma
Sub
Lotion
1%, 100 ml GH CHC PHC
Benzene
centre
IPD
OPD
OT
OPD
OPD
OPD
OPD
OPD
OPD
OPD
OPD
OPD
OPD
OPD
OPD
OPD
Page 26
200
117
201
118
202
119
203
204
Solution
205
Solution
206
120
207
208
209
121
210
211
122
212
123
213
214
124
Hexachlori
Cream
1%, 25 gm
de
13. DISINFECTANTS AND ANTISEPTICS
13.1 Antiseptics
Hydrogen
Solution
1%
Peroxide
20% conc.
Cetrimide
Solution
for dilution
Chlorhexidi
5% conc.
Solution
ne
for dilution
215
125
216
126
217
127
218
Povidone
iodine
Solution
5%,500ml,
10%, 500
ml
5%,5 litre
CHC
PHC
GH
CHC
PHC
OT
GH
CHC
PHC
OT
GH
CHC
PHC
GH
CHC
PHC
OT
OT
GH
OT
CHC
PHC
5%,15gm
GH
CHC
PHC
Ointment
5%,250 gm
GH
CHC
PHC
GH
CHC
PHC
7.5%, 500
ml
13.1 Antiseptics(Complementary)
1%, 100
Cream
gm
Framycetin
Cream
1 % 20gm
13.2 Disinfectants
Bleaching
Powder
powder
Glutraldeh
Solution
2% / 2.4%
yde
14. MEDICINES FOR UROLOGY
14.1 DIURETICS
Tablet
40 mg
Furosemid
10 mg/ml
e
Injection
2-ml
ampoule
Injectable
20%, 350
Mannitol
solution
ml
Spironolact
Tablet
25 mg
one
14.2 Medicines for BPH
Tamsulosin
Hydrochlor Tablet
0.4 mg
ide
Sub
centre
Sub
centre
GH
Ointment
Scrub
Sub
OPD
centre
GH
OT
Sub
centre
Sub
OPD
centre
Sub
centre
GH
IPD
IPD
GH
CHC
PHC
GH
CHC
PHC
GH
CHC
GH
CHC
PHC
GH
CHC
PHC
GH
CHC
GH
GH
IPD
OPD
Sub
centre
OT
IPD
OPD
IPD
IPD
OPD
CHC
OPD
Page 27
128
219
129
220
130
221
222
131
223
132
224
133
225
Tamsulosin
+
0.4 mg +
Tablet
GH
Dutasterid
0.5 mg
e
Flavoxate
Hydrochlor Tablet
200 mg
GH
ide
14.3 Alkalising Solution
Disodium
1.38
Hydrogen
Suspension
GH
gm/100 ml
Citrate
15. GASTROINTESTINAL MEDICINES
15.1 Antacids and other antiulcer medicines
Aluminium
250 mg
Chewable
hydroxide
+250 mg + GH
Tablet
+
25 mg
magnesium
300 mg+
hydroxide
Oral
150 mg+
+
GH
suspension
40 mg/ 5
Simethicon
ml, 180 ml
e
Aluminium
hydroxide
+
magnesium
240
hydroxide
Chewable
mg+100
GH
+
Tablet
mg+25 mg
Simethicon
+60 mg
e+
magnesium
Carbonate
Omeprazol
Capsule
20 mg
GH
e
226
134
CHC
OPD
CHC
PHC
OPD
CHC
PHC
OPD
CHC
PHC
OPD
CHC
PHC
OPD
CHC
PHC
OPD
Sub
OPD
centre
Tablet (HCL)
150 mg
GH
CHC
PHC
Injection
25 mg/ml
in 2-ml
amp
GH
CHC
PHC
Tablet
10 mg
GH
CHC
PHC
Suspension
1 mg/ ml,
30ml
GH
CHC
PHC
Tablet
25 mg
GH
CHC
PHC
Ranitidine
227
OPD
IPD
15.2 Antiemetic medicines
228
135
229
136
230
Domperido
ne
Cinnarizine
Sub
OPD
centre
Sub
OPD
centre
OPD
Page 28
231
137
232
138
139
233
234
235
236
237
238
140
239
240
141
241
142
242
143
243
144
244
245
145
246
Metoclopra
mide
Ondansetr
on
Tablet
(Hydrochlorid
e)
Injection
(hydrochlorid
e)
Tablet
Injection
Tablet
Tablet
Injection
Tablet
(hydrochlorid
e)
Elixir or syrup
Promethazi
(hcl)
ne
Injection
(hydrochlorid
e)
10 mg
GH
CHC
PHC
5 mg/ ml in
GH
2-ml amp
CHC
PHC
PHC
OPD
IPD
5 mg
12.5 mg/ml
4 mg
8 mg
2 mg/ ml
2ml
ampoule
GH
GH
GH
GH
CHC
CHC
CHC
PHC
PHC
IPD
IPD
IPD
GH
CHC
PHC
IPD
25 mg
GH
CHC
PHC
OPD
5 mg/ 5 ml
GH
CHC
PHC
OPD
25 mg/ml
in 2-ml
amp
GH
CHC
PHC
GH
CHC
GH
CHC
PHC
OPD
GH
CHC
PHC
Sub
OPD
centre
GH
CHC
PHC
OPD
GH
CHC
PHC
OPD
GH
CHC
PHC
Doxylamin Tablet
10 mg
e succinate
15.3 Antihaemorrhoidal medicines
Local
anaesthetic
, astringent
and
Ointment or
antisuppository
inflammato
ry
medicines
15.4 Antispasmodic medicines
Tablet
Dicyclomin
(hydrochlorid 10 mg
e
e)
Mephenam
ic Acid +
500 mg
Tablet
Dicyclomin
+20 mg
e
Tablet
80 mg
Drotaverin
40 mg/ 2
e
Injection
ml
OPD
IPD
OPD
IPD
Page 29
146
247
248
147
249
148
250
251
149
252
253
150
254
151
255
152
256
257
258
153
154
259
155
260
156
261
262
157
263
Hyoscine
Tablet
10 mg
butyl
Injection
20 mg/ ml
bromide
15.5 Laxatives
Bisacodyl
Tablet
5 mg
Milk of
11.25 ml +
Magnesia
3.75 ml/ 15
Suspension
+Liquid
ml (50 ml
Paraffin
Packing)
15.6 Medicines used in Diarrhoea
Powder for
As per IP
Oral
solution
rehydratio
Powder for
n salts
For 200 ml
solution
Tablet
20 mg
(Sulphate)
Zinc
Suspension
20 mg/5
(Sulphate)
ml
16. HORMONES
16.1 Insulins and other antidiabetic
Glibenclam
Tablet
5 mg
ide
Glimipride Tablet
1 mg
Tablet
40 mg
* Gliclazide
Tablet
80 mg
Biphasic
Isophane
(R-DNA
Injection
40 I.U/ml
origin
30/70
Insulin
40 IU/ml in
Injection
(soluble)
10 ml vial
Intermedia
te-acting
insulin
(Lente)
Injection
Tablet
(hydrochlorid
e)
Metformin
Tablet
(hydrochlorid
e)
16.2 Ovulation inducers
GH
CHC
PHC
OPD
GH
CHC
PHC
GH
CHC
PHC
OPD
GH
CHC
PHC
OPD
GH
CHC
PHC
GH
CHC
PHC
GH
CHC
PHC
GH
CHC
PHC
GH
CHC
PHC
GH
GH
GH
CHC
CHC
CHC
IPD
Sub
centre
Sub
centre
Sub
centre
Sub
centre
OPD
OPD
OPD
OPD
OPD
OPD
OPD
OPD
GH
IPD
GH
IPD
40 IU/ml in
GH
10 ml vial
IPD
500 mg
GH
1 gm SR
GH
CHC
PHC
OPD
OPD
Page 30
158
264
159
265
160
266
161
267
162
268
163
269
164
270
271
272
165
273
166
274
167
275
168
276
Tablet
(citrate)
16.3 Progestogens
Medroxypr
ogesterone Tablet
acetate
Progestero
Tablet
ne
Clomifene
50 mg
GH
OPD
10mg
GH
OPD
100 mg
GH
OPD
Norethister Tablet
5 mg
GH
OPD
one
16.4 Thyroid hormones and antithyroid medicines
Levothyrox Tablet
50 mcg
GH CHC PHC
OPD
ine
(sodium)
Carbimazol
Tablet
5 mg
GH
OPD
e
17. IMMUNOLOGICALS
17.1 Diagnostic agents
All tuberculins should comply with the WHO Requirements
Tuberculin,
purified
2 T.U./0.1
protein
Injection
GH
IPD
ml
derivative
(PPD)
17.2 Sera and immunoglobulins
All plasma fractions should comply with the WHO Requirements for the Collection,
Processing and Quality Control of Blood, Blood Components and Plasma Derivatives.
Anti-RHO50 mcg /
Injection
GH CHC PHC
IPD
D
vial
Immunoglo
150
Injection
GH
IPD
bulin(Hum
mcg/vial
an)
Injection
(Polyclonal
300mcg/vi
Injection
GH CHC PHC
IPD
)
al
(Thiomersa
l Free)
17.3 For specific groups of individuals
Tetanus
0.5 ml
Sub
Injection
GH CHC PHC
IPD
vaccine
Ampoule
centre
1 % vial, 10
Hepatitis B
Sub
Injection
mg/ml, 10 GH CHC PHC
IPD
vaccine
centre
ml vial
Anti
Injection ID
1 ml
GH CHC PHC
IPD
Page 31
277
169
278
170
279
171
280
172
281
173
282
283
174
284
175
285
176
286
177
287
178
288
179
289
180
290
Rabies
vaccine
(ChickInjection IM
0.5 ml
GH CHC PHC
IPD
Embryo/Ve
rocell/Hum
an Diploid)
18. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE
INHIBITORS
Atracurium Injection
besylate
Succinyl
Choline
Injection
Vial
10 mg/ ml
GH
OT
50 mg/ml
GH
OT
500 mcg/
Injection
ml in 1 ml
GH
amp
19. OPHTHALMOLOGICAL PREPARATIONS
19.1 Anti-infective agents
Chloramph
Ointment
1%
GH
enicol
Neostigmin
e (methyl)
Ciprofloxac
in
Drops
0.3%
GH
Ointment
0.3%
GH
Ciprofloxac
in +
0.3%
Eye Drops
GH
Dexametha
+0.1%
sone
Tobramyci
0.3%w/v, 5
Eye drops
GH
n
ml
Moxifloxaci
0.5%w/v, 5
Eye drops
GH
n
ml
19.3 Anti-inflammatory agents
Prednisolo
Eye drops
1%
GH
ne (sodium
phosphate)
Flurbiprofe
Eye Drop
0.03%
GH
n
Flouromet
Eye drops
0.1% w/v
GH
halone
19.5 Miotics and antiglaucoma medicines
Acetazolam
Tablet
250 mg
GH
OT
CHC
PHC
CHC
PHC
Sub
OPD
centre
Sub
OPD
centre
OPD
OPD
OPD
OPD
OPD
OPD
OPD
OPD
Page 32
ide
181
182
291
292
293
183
294
184
295
185
296
186
297
187
298
188
299
300
Pilocarpine
(hydrochlo
ride or
nitrate)
Timolol
(maleate)
Eye drops
Eye drops
Eye drops
19.6 Mydriatics
Cyclopento
Eye Drop
late
Tropicamid
e+
Eye Drops
Phenyleph
erine
19.7 Lubricating
Hydroxypr
opyl
Injection
mehtylcell
ulose
19.8 Anti Allergic
Anti
Eye Drops
Allergic
Disodium
Cromoglyc Eye Drops
ate
20. NASAL ENT
Drops
Xylometaz
Drops
oline
2%
0.25% , 5
ml
0.5%, 5 ml
GH
OPD
GH
OPD
GH
OPD
1% w/w
GH
IPD
0.8% + 5%
GH
IPD
2%
GH
IPD
GH
CHC
PHC
OPD
GH
CHC
PHC
OPD
0.05%,
GH
CHC
PHC
OPD
0.1%
GH
CHC
PHC
OPD
189
301
Saline
Nasal Drops
0.6%
GH
CHC
PHC
Sub
OPD
centre
190
302
Glycerin
Solution
500 gm
bottle
GH
CHC
PHC
OPD
303
Paradichlor
benzene +
Benzocain
+
Ear Drops
Chlorbutol
+
Turpentine
Oil
2 % + 2.7
%+5%+
15 %
GH
CHC
PHC
OPD
191
Page 33
192
304
193
305
306
194
307
195
308
196
309
197
310
198
311
312
199
313
314
200
201
315
316
Chloremph
enicol
+Beclomet
hasone
5 % w/v +
dipropoina
0.025%
te
Ear Drops
w/v + 1 %
+Clotrimaz
w/v + 2 %
ole +
w/v
lignocaine
Hydrochlor
ide HCL
Clotrimazol
Ear Drops
e
21. OXYTOCICS AND ANTIOXYTOCICS
21.1 Oxytocics
Methyl
ergometrin
e
Tablet
125 mcg
GH
CHC
PHC
OPD
GH
CHC
PHC
OPD
GH
CHC
PHC
Sub
OPD
centre
CHC
PHC
Sub
centre
IPD
CHC
PHC
Sub
centre
IPD
200 mcg in
Injection
1 ml
GH
ampoule
5 IU in 1 ml
Oxytocin
Injection
GH
ampoule
21.1 Oxytocics (Complementary)
25
Carboprost Injection
mg/ml(250 GH
mcg)
Dinoprosto
0.5 mg, 3
Gel
GH
ne
gm
Mifepriston
Tablet
200 mg
GH
e
Tablet
25 mcg
GH
Misoprosto
Tablet
200 mcg
GH
l
21.2 Antioxytocics
Tablet
10 mg
GH
Isoxsuprin
e
Injection
5 mg/ ml
GH
(hydrochlo
ride)
Valethemat
Injection
8mg/ml
GH
e
22. PSYCHOTHERAPEUTIC MEDICINES
22.1 Medicines used in psychotic disorders
IPD
IPD
CHC
OPD
IPD
Sub
centre
CHC
PHC
IPD
CHC
PHC
CHC
PHC
IPD
CHC
PHC
IPD
OPD
Page 34
202
203
317
318
319
204
320
205
321
206
322
207
323
208
324
209
325
210
326
212
327
328
329
213
330
214
331
215
332
216
333
211
Chlorprom
azine
(hydrochlo
ride)
Fluphenazi
ne
(Decanoate
)
Haloperido
l
Tablet
50 mg
GH
Injection
25 mg, 1
ml
ampoule
GH
Tablet
Injection
5 mg
5 mg , 1 ml
ampoule
GH
GH
OPD
IPD
OPD
IPD
Risperidon
Tablet
2gm
GH
OPD
e
Quetiapine Tablet SR
50 mg
GH
OPD
22.2 Medicines used in depressive disorders
Amitriptyli
ne
Tablet
10 mg
GH CHC
OPD
(hydrochlo
ride)
Fluoxetine
(hydrochlo Capsule
20 mg
GH CHC PHC
OPD
ride)
Sertraline Tablet (SR)
50 mg
GH
OPD
22.3 Medicines used in bipolar disorders
Lithium
Tablet
300 mg
GH
OPD
carbonate
22.4 Medicines used in generalized anxiety and sleep disorders
Tablet
0.25 mg
GH CHC PHC
OPD
Alprazolam Tablet
0.5 mg
GH CHC PHC
OPD
Donepezil Tablet
5 mg
GH
OPD
Clonazepa
Tablet
0.5mg
GH
OPD
m
22.5 Medicines used for Deaddiction
Bupropion Tablet
150mg
GH
OPD
Buprenorp Tablet
0.4mg
GH
OPD
hine
(Sublingual)
23. MEDICINES ACTING ON THE RESPIRATORY TRACT
23.1 Antiasthmatic and medicines for chronic obstructive pulmonary disease
Cough
Expectoren
Salbutamol
t
2 mg +
Syrup
GH CHC PHC
OPD
(Salbutamo
Bromhexin
l 2 mg +
e 4 mg
Bromhexin
Page 35
e 4 mg)
Inhalation –
aerosol
334
217
335
Salbutamol
336
218
337
Beclometh
asone +
Salbutamol
338
219
339
340
220
341
342
221
343
344
222
345
346
223
347
224
348
225
349
226
350
Suspension
Nebulizer
solution
(sulphate)
5 mg/ ml
Inhalation
(MDI)
Tablet
Etophylline
Tablet
+
Theophylli
ne
Injection
Budesonid
e
100
microgram
s/ dose
2 mg/5 ml
Nebulizer
solution
GH
CHC
PHC
OPD
GH
CHC
PHC
OPD
GH
CHC
PHC
GH
115 mg +
35 mg,
231 mg +
69 mg
169.4 mg +
56.6 mg/2
ml
15 ml vial
IPD
OPD
GH
CHC
PHC
OPD
GH
CHC
PHC
OPD
GH
CHC
PHC
GH
CHC
IPD
IPD
Tablet
2 mg
GH CHC PHC
OPD
(sulphate)
Salbutamol
Tablet
4 mg
GH CHC PHC
OPD
(sulphate)
24. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID-BASE DISTURBANCES
24.1 Parenteral
Injectable
5%,
Sub
GH CHC PHC
IPD
solution
isotonic
centre
10%
Glucose/de Injectable
GH
IPD
solution
isotonic
xtrose
Injectable
25%
GH
IPD
Glucose
5% glucose
with
Injectable
+ 0.9%
sodium
GH CHC PHC
IPD
solution
sodium
chloride/sa
chloride
line
Isolyte – P Injection
GH CHC PHC
IPD
Potassium Injectable
11.2% in
GH
IPD
chloride
solution
20ml
Ringer
Injectable IV
Sub
GH CHC PHC
IPD
lactate
solution
centre
Page 36
227
351
228
352
229
353
230
354
231
355
356
Sodium
Injectable IV
bicarbonat
7.5%
solution
e
Sodium
Injectable
0.9%
chloride
solution
isotonic
24.2 Miscellaneous
Water for
5ml
Injection
injection
ampoule
25. VITAMINS AND MINERALS
Ascorbic
Tablet
500 mg
acid
Calcium
salts
Tablet
500 mg
Syrup
GH
CHC
PHC
IPD
GH
CHC
PHC
IPD
GH
CHC
PHC
IPD
GH
CHC
PHC
GH
CHC
PHC
GH
Sub
OPD
centre
OPD
OPD
232
357
Pyridoxine
HCl
Tablet
10 mg
GH
233
358
Vitamin A
Suspension
100000
IU/ml
GH
CHC
PHC
234
359
360
361
Multi
Vitamin
Syrup
Injection
Drops
GH
GH
GH
CHC
CHC
CHC
PHC
PHC
PHC
362
B-Complex
Tablet
GH
CHC
PHC
235
363
236
364
365
237
366
367
238
368
369
239
370
240
371
372
373
241
374
OPD
Sub
OPD
centre
OPD
IPD
OPD
Sub
OPD
centre
Cholecalcifero
1000 IU
GH CHC PHC
OPD
l sachets
Vitamin D
Drops
4000IU
GH CHC PHC
OPD
Tablet
60000 IU
GH CHC PHC
OPD
(Chewable)
26. ANTIMALARIAL MEDICINES (TO BE PROCURED AT STATE LEVEL)
Tablet
50 mg
GH CHC PHC
OPD
Artesunate
Injection
60 mg/ml
GH CHC
80 mg/ml,
Artemether Injection
GH CHC
1 ml amp
Sub
150 mg
Chloroquin
Tablet
GH CHC PHC Centr OPD
base
e
e
(Phosphate
50 mg/ 5
)
Suspension
GH CHC
OPD
ml
2.5 mg
GH CHC PHC
OPD
Primaquine Tablet
(Diphospha Tablet
7.5 mg
GH CHC PHC
OPD
te)
Tablet
15 mg
GH CHC PHC
OPD
Quinine
300 mg/
(Dihydroch Injection
ml, 2ml
GH CHC
loride)
ampoule
IPD
IPD
IPD
Page 37
242
375
Sulfadoxine
+
Tablet
Pyrimetha
mine
500 mg +
25 mg
GH
CHC
PHC
OPD
Page 38
Page 39
Schedule D
Revised Haryana EML( Drugs Approved for Local Purchase)
Total Drugs = 44
Total Components = 52
* All the drugs to be dispensed in OPD will be made available in IPD as and when required.
* All drugs in OPD,IPD should be made available in OT as and when required.
* The column IPD combines the drugs to be made available at different work stations of the
hospital like wards,injection room,Labour Room, emergency department,ICU,SNCU,minor OT or
any other.
Drugs
Sr.
No.
Comp.
Sr. No.
Medicines
Dosage
Forms
Strength
Category
GH
CHC
Usage
PHC/ Sub
UD
centre
OPD
IPD OT
1. ANAESTHETICS
1.1 General anesthetics and oxygen
1
1
Nitrous
oxide
Inhalation
GH
2
2
Oxygen
Inhalation
(medicina
l gas)
GH
CHC
GH
CHC
OT
PHC
Sub
centre
OT
1.2 Local anaesthetics
3
3
4
Lignocaine
Hydrochlori
de
Injection ( 2%, 2 ml
Heavy)
vial
OT
4%, 30 ml
GH
vial
2. ANALGESICS, ANTIPYRETICS, NON-STEROIDAL ANTI-INFLAMMATORY
MEDICINES (NSAIMs), MEDICINES USED TO TREAT GOUT AND DISEASE
MODIFYING AGENTS IN RHEUMATOID DISORDERS (DMARDs)
Injection
2.3 Medicines used to treat gout
4
5
Allopurinol
Tablet
100 mg
GH
CHC
PHC
OPD
Page 40
OT
3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS
5
6
6
7
Methyl
Prednisolon
e
Adrenaline
Injection
1 gm vial
GH
Injection
1 mg/ml
(1:1000) (
GH
1 ml
ampoule)
IPD
CHC
PHC
IPD
4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING
4.1 Non-specific
8
7
9
Charcoal
activated
Tablet
250 mg
Tablet
500 mg
GH
IPD
GH
IPD
4.2 Specific
8
10
Calcium
gluconate
Injection
9
11
Naloxone
Injection
(hydrochl
oride)
100
mg/ml,
10 ml
amp
400
mcg,1ml
ampoule
10
12
Pralidoxime
(PAM)
Injection
1 gm vial
GH
CHC
GH
GH
IPD
IPD
CHC
IPD
4.2 Specific (Complementary)
11
13
12
14
13
15
Disodium
Edetate
Penicillamin
e
Deferiprone
(Iron
Chelator)
Injection
150
mg/mL
,2ml
ampoule
GH
IPD
Capsule/
Tablet
250 mg
GH
IPD
Tablet/ca
psule
250 mg
GH
IPD
5. ANTICONVULSANTS/ANTIEPILEPTICS
Page 41
14
16
Clobazam
Tablet
10 mg
GH
OPD
6. ANTI-INFECTIVE MEDICINES
6.2.1 Beta Lactam Medicines(Complementary)
17
15
18
Ceftazidime
(pentahydra
te)
Injection
powder
250 mg
GH
IPD
Injection
powder
1 g vial
GH
IPD
250 mg
GH
OPD
6.3 Antifungal medicines
16
19
Griseofulvin
Tablet
8. ANTIPARKINSONISM MEDICINES
20
17
21
Levodopa +
Carbidopa
Tablet
100 mg +
10 mg
GH
OPD
Tablet
250 mg
+25 mg
GH
OPD
8. ANTIPARKINSONISM MEDICINES(Complementary)
18
22
Bromocripti
ne
Tablet
(mesylate
)
2.5 mg
GH
OPD
9. MEDICINES AFFECTING THE BLOOD
9.2 Medicines affecting coagulation
19
23
24
20
25
Heparin
sodium
Warfarin
(sodium)
Injection
5000 IU/
ml
GH
Tablet
2 mg
GH
OPD
Tablet
5 mg
GH
OPD
IPD
9.2 Medicines affecting Coagulation(Complementary)
21
26
Protamine
sulphate
(Heparin
Injection
10
mg/ml, 5ml
GH
IPD
Page 42
Antagonist)
ampoule
11. CARDIOVASCULAR MEDICINES
11.1 Antianginal medicines
27
22
Tablet
10 mg
GH
CHC
PHC
OPD
Tablet
40 mg
GH
CHC
PHC
OPD
Propranolol
28
11.2 Antiarrhythmic medicines
23
29
Amiodarone Tablet
100 mg
GH
IPD
24
30
Verapamil
40 mg
GH
IPD
Tablet
11.3 Antihypertensive medicines
25
31
Nifedipine
Capsule(S
5 mg
ublingual)
GH
IPD
26
32
Labetolol
Injection
GH
IPD
20 mg
Methyldopa & Labetalol is listed for use in the management of pregnancy-induced
hypertension only. Its use in the treatment of essential hypertension is not
recommended in view of the availability of more evidence of efficacy and safety of
other medicines.
11.4 Medicines used in heart failure
27
28
33
34
Dobutamine Injection
Dopamine
Injection
(hydrochl
oride)
125 mg/
5 ml
40 mg/
ml in 5ml
Ampoule
GH
GH
IPD
CHC
IPD
12. DERMATOLOGICAL MEDICINES (topical)
12.1 Skin(Complementary)
29
35
Trichloroace
Crystal
tic Acid
GH
OT
Page 43
12.2 Anti-infective medicines
36
30
37
Potassium
permangana
te
Aqueous
solution
1 : 10 000
GH
CHC
PHC
IPD
Crystal
100 gm
GH
CHC
PHC
IPD
GH
CHC
PHC
IPD
GH
CHC
14. MEDICINES FOR UROLOGY
14.3 Alkalising(Complementary)
31
38
Sodium
Bicarbonate
Injection
7.5%
15. GASTROINTESTINAL MEDICINES
15.5 Laxatives
32
39
Glycerine
Saline
Enema
IPD
16. HORMONES
16.4 Thyroid hormones and antithyroid medicines
33
40
Propylthiour
Tablet
acil
50 mg
GH
OPD
17. IMMUNOLOGICALS
17.2 Sera and immunoglobulins
34
41
35
42
36
43
Anti Rabies
3000 IU
Immunoglob Injection
GH
IPD
/ml
ulin
18. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE
INHIBITORS
Vecuronium
4 mg Dry
(bromide
Injection
Powder/
GH
powder )
Ampoule
Recronium
10 mg/
Injection
GH
Bromide
ml
19. OPHTHALMOLOGICAL PREPARATIONS
Page 44
OT
OT
19.1 Anti-infective agents
37
44
Acylovir
Eye Oint
5%, 5 gm
GH
OPD
GH
OPD
19.2 Anti Fungal
38
45
Natamycin
Eye Drops 2%
19.4 Miscellaneous
39
46
Hyaluronida
se
40
47
Tryphen
Blue Dye
Injection
1500 IU/
ml
GH
OT
GH
OT
19.6 Mydriatics
41
48
49
42
50
Atropine
(sulphate)
Homatropin
e
Drops
1%
GH
IPD
Ointment
1%
GH
IPD
Eye Drops 1%
GH
IPD
23. MEDICINES ACTING ON THE RESPIRATORY TRACT
23.1 Antiasthmatic and medicines for chronic obstructive pulmonary disease
43
51
Aminophylli
ne
44
52
Ipratropium
Nebulizin
bromide –
g Solution
aerosol
Injection
25 mg/
ml, 10 ml
ampoule
GH
GH
CHC
IPD
IPD
Page 45
Schedule E
List of Drugs from STG approved for Local Purchase
Sr No.
Sub Sr. No.
Name of Drug
1
A.1
Tab Nicorandil
2
A.2
Tab Cyclizine
3
A.3
Cap Pancreatin 170 mg
4
A.4
Human Tetanus Immunoglobulin 3000-5000U
5
A.5
Tab Nimodipin
6
A.6
Human Immunoglobulin
7
A.7
Tab Cyclosporin A
8
A.8
Tab Pyridium
9
A.9
Tab Duloxetine
10
A.10
Capsaicin Cream 0.025-0.075%
11
A.11
Tab Sodium & potassium phosphate 1-1.5 mg
12
A.12
Tab Flucytosine
13
A.13
Hydrocortisone enema
14
A.14
Inj. Pancuronium
15
A.15
Inj sodium iodide 1gm
16
A.16
Sodium Poilstyrene sulphonate solution 10%
17
A.17
Inj. Flumazenil
18
A.18
Ethyl alocohol
19
A.19
Inj. Desferrioxamine
20
A.20
Inj Thiamine
Page 46
21
A.21
Inj. Pyridoxin
22
A.22
Syrup Ipecac
23
A.23
Inj. Fomipezole
24
A.24
Inj Paraldehyde
25
A.25
Sodium thiosulphate 25% solution
26
A.26
Sodium nitrite 3% soln
27
A.27
Inj. Methylene blue
28
A.28
Inj. Physostigmine 0.56 mg
29
A.29
N-acetyl cysteine oral
30
A.30
Zinc oxide paste (Petroleum jelly 50%, zinc oxide
50%)
31
A.31
Hydrocortisone -17 butyrate ointment or cream
32
A.32
Salicyclic acid 3 %
33
A.33
Silver nitrate sol 0.25%
34
A.34
Retinoic acid Cream/Gel 0.25%
35
A.35
Intralesional Triamcinolone 10mg/ml
36
A.36
Intralesional Triamcinolone acetonide injections
37
A.37
Halcinoide ointment
38
A.38
Tar (6% in white vaseline) topical solution
39
A.39
Modified kligman formula contain Hydrocortisone
1`%, Hydroquinone 2%, Tretinoin 0.025 %
40
A.40
Hydroquinone cream/lotion 5%
41
A.41
Glycolic acid cream 6-12%
42
A.42
Topical psoralen photochemotherapy
43
A.43
Tab. Methoxsalen 10 mg
Page 47
44
A.44
Nephazolin Eye drop
45
A.45
Chlormycetin Eye drop
46
A.46
Dexamethasone eyedrops 0.01%
47
A.47
Natamycin 5% suspension
48
A.48
Acyclovir 3% Eye Ointment
49
A.49
Tab Mementin HCL
50
A.50
Tab Naloxone
51
A.51
Tab Sildenafil
52
A.52
Inj Testosterone Enanthate
53
A.53
Tab Disulfiram
54
A.54
Tab Naltrexaone
55
A.55
Tab Acamprosate
56
A.56
Tab Tibolone
57
A.57
Tab Colchicine
58
A.58
Tab Risedronate 5 mg
59
A.59
Tab Risedronate 35 mg
60
A.60
Diazepam Rectal liquid
61
A.61
Calcium gluconate 10% solution
62
A.62
10 % Ichthamol in glycerin soaked wick pack
63
A.63
Antibiotic steroid wick pack (Polymyxin B sulphate
500 IU, Neomycin sulphate 3400 IU,Zinc bacitracin
400 IU, HydrocORtisone 10 mg/g)
64
A.64
Tab Ambroxol 75mg
65
A.65
Syrup Ambroxol
66
A.66
Tab Mefloquine
Page 48
67
A.67
Tab Osltamivir
68
A.68
Syp. Osltamivir 12 mg /ml
69
A.69
Tab Clarithromycin
70
A.70
Tab Pyrimethamine + Tab Sulphadiazine
71
A.71
Inj Penicillin G
72
A.72
Tab Quinine
73
A.73
Inj Cloxacillin
74
A.74
Inj Acyclovir
75
A.75
Inj Pentamidine Isoethionate
76
A.76
Inj. Nafcillin
77
A.77
Inj Clindamycin
78
A.78
Inj Benzathin Benzylpencillin
79
A.79
Inj. Cefoxitin
B. List of Drugs from STG having alternative in Haryana EML
Sr. No.
Sub Sr. No.
Drug Name
80
B. 1
Tablet Betahistine 8 mg
81
B. 2
Tablet Betahistine 16 mg
82
B. 3
Inj. Fosphenytoin
83
B. 4
Inj. sodium valporate
84
B. 5
Terbutaline by aerosol Inhale
85
B. 6
1% Silver nitrate cream
86
B. 7
Hartman solution
87
B. 8
Tab Frusemide 20 mg+ Spironolactone 50
88
B. 9
Tab Benzthiazide 25 mg + Triamterene 50 mg
Page 49
89
B. 10
Tab Idapamide
90
B. 11
Tab Lisinopril
91
B. 12
Tab Prazosin
92
B. 13
Tab Clonidine
93
B. 14
Inj. Nitroprusside
94
B. 15
Inj Hydralazine
95
B. 16
Inj phentolamine
96
B. 17
Inj Digoxin (Rapid digitilization)
97
B. 18
Inj. Verapamil
98
B. 19
Inj. Metoprolol
99
B. 20
Inj. Erythromycin
100
B. 21
CapTetracycline
101
B. 22
Hydrocortisone pellets
102
B. 23
Tab Mosapride
103
B. 24
Cap Lansoprazole
104
B. 25
Tab Pentoprazole 20mg
105
B. 26
Tab Pentoprazole 40 mg
106
B. 27
Magnesium sulphate suspension
107
B. 28
Tab Sodium picosulphate
108
B. 29
Isotonic polyethylene glycol (PEG) soln
109
B. 30
Tab Mebavaerine hcl
110
B. 31
Tab Propanthaline hcl
111
B. 32
Tab Mesalazine
112
B. 33
Tab Osalazine
Page 50
113
B. 34
Tab Atovaquone
114
B. 35
Tab Ergotamine
115
B. 36
Tab Ergotamine(1 mg) + Caffeine (100 mg)
116
B. 37
Suppositary Ergotamine(2 mg) + Caffeine (100 mg)
117
B. 38
Tab Sumatriptan
118
B. 39
Inj Sumatriptan
119
B. 40
Tab Topiramate
120
B. 41
Inj. Meropenam
121
B. 42
Glycerol soln
122
B. 43
Tab Rivastigmine
123
B. 44
Tab Pramipixol
124
B. 45
Tab Ropinirole
125
B. 46
Tab Peribidil
126
B. 47
Tab Captopril
127
B. 48
Tab Chlorambucil
128
B. 49
Tab Gabapentin 600 mg
129
B. 50
Tab Gabapentin 75 mg
130
B. 51
Tab Pregabalin 75mg
131
B. 52
Tab Pregabalin 150 mg
132
B. 53
Tab Levocetrizine
133
B. 54
Tab Fexofenadine Hcl 120mg
134
B. 55
Tab Pheniramine Maleate
135
B. 56
Betamethasone nasal drop or
136
B. 57
Budenoside intranasal spray or
Page 51
137
B. 58
Tab Betamethasone
138
B. 59
Eye drop Chloramphenicol 1%
139
B. 60
Eye ointment Tetracycline HCL
140
B. 61
Eye drop/ointment Norfloxacin
141
B. 62
Eye drop Olopatadine
142
B. 63
Betaxolol E/D
143
B. 64
Travoprost E/D
144
B. 65
Dorzolamide E/D
145
B. 66
Brimonidine tartrate E/D
146
B. 67
Cefazolin E/D
147
B. 68
Ofloxacin E/D
148
B. 69
Ketoconazole E/D
149
B. 70
Ganciclovir E/D
150
B. 71
Tab Terbinafine
151
B. 72
Cream 1% Ciclopirox
152
B. 73
Cap Itraconazole
153
B. 74
Gel Benzyl peroxide
154
B. 75
Tab Minocycline
155
B. 76
Tab Famcyclovir
156
B. 77
Tab Evening primrose oil
157
B. 78
Tab Trifluoperazine
158
B. 79
Tab Mirtazapine
159
B. 80
Tab Buspirone
160
B. 81
Tab Fluvoxamine
Page 52
161
B. 82
Tab Zolpidem
162
B. 83
Tab Oxazepam
163
B. 84
Nicotine gum
164
B. 85
Tab Piroxicam
165
B. 86
Tab Febuxostat
166
B. 87
Inj Vitamin A
167
B. 88
Cap .Vitamin A
168
B. 89
Tab Chloramphenicol
169
B. 90
Inj. Chloramphenicol
170
B. 91
Oral Penicillin V
171
B. 92
Inj. Crystalline penicillin
172
B. 93
Inj. Pentamidine
173
B. 94
Syp Nalidixic acid
Page 53